Ligand ID: BA0

Drugbank ID:
Zanubrutinib
(DB15035)

Indication:
Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.

LIST OF BINDING INTERFACES for query 'DB15035'
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details
6J6M_A_BA0A701	6j6m	BA0	Zanubrutinib (DB15035)	Homo sapiens	TYROSINE-PROTEIN KINASE BTK	PK_Tyr_Ser-Thr	22	LEU A 408 THR A 410 VAL A 416 ALA A 428 LYS A 430 MET A 449 VAL A 458 ILE A 472 THR A 474 GLU A 475 TYR A 476 MET A 477 GLY A 480 CYS A 481 LEU A 483 ASN A 484 ARG A 525 LEU A 528 SER A 538 ASP A 539 PHE A 540 LEU A 542	BA0 A 701		Details
DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details

[["6J6M_A_BA0A701","6j6m","BA0","Zanubrutinib (DB15035)","Homo sapiens","TYROSINE-PROTEIN KINASE BTK","PK_Tyr_Ser-Thr",22,"LEU A 408;THR A 410;VAL A 416;ALA A 428;LYS A 430;MET A 449;VAL A 458;ILE A 472;THR A 474;GLU A 475;TYR A 476;MET A 477;GLY A 480;CYS A 481;LEU A 483;ASN A 484;ARG A 525;LEU A 528;SER A 538;ASP A 539;PHE A 540;LEU A 542","BA0 A 701\r"]]